Gipson Debbie S, Ferris Maria E, Dooley Mary Anne, Huang Kui, Hogan Susan L
Divisions of Nephrology and Hypertension and Rheumatology, University of North Carolina-Chapel Hill, NC, USA.
Am J Kidney Dis. 2003 Feb;41(2):455-63. doi: 10.1053/ajkd.2003.50056.
This study was conducted to determine renal allograft and patient survival for children with lupus nephritis compared with pediatric allograft recipients with other causes of end-stage renal disease.
Data from the United Network for Organ Sharing registry for children aged 1 to 21 years who received an initial renal transplant between 1987 and 1997 were included. Subjects with kidney failure caused by other vasculitides were excluded, as were those with multiple organ transplants.
A total of 7,926 children (n = 254 children with lupus) were available for evaluation. Patients with lupus were older (median age, 19 versus 15 years; P < 0.01) and more commonly female (80% versus 40%; P < 0.01) and black (34% versus 20%; P < 0.01) than patients without lupus. Median follow-up was 4.2 years (range, 0.03 to 13 years). Renal allograft survival was not different between groups when adjusting for sex, race, age, and cadaveric (CAD) transplant (P = 0.98). Among patients with lupus, those with CAD allografts were 1.9 times (95% confidence interval [CI], 1.1 to 3.3; P = 0.02) more likely to lose their graft than those with living donor grafts. This increased risk for graft failure with CAD transplants was observed to a lesser degree in subjects without lupus (hazard ratio, 1.3; 95% CI, 1.2 to 1.5). Patients with lupus were 1.8 times more likely to die compared with patients without lupus in multivariate analysis (95% CI, 1.14 to 2.74; P = 0.01).
Although allograft survival is not different, patient survival after renal transplantation is less for pediatric patients with lupus compared with other pediatric renal allograft recipients.
本研究旨在确定狼疮性肾炎患儿肾移植后的移植物及患者生存率,并与因其他终末期肾病接受肾移植的儿科患者进行比较。
纳入1987年至1997年间接受首次肾移植的1至21岁儿童的器官共享联合网络登记数据。排除由其他血管炎导致肾衰竭的受试者以及接受多器官移植的受试者。
共有7926名儿童(n = 254名狼疮患儿)可供评估。狼疮患者比非狼疮患者年龄更大(中位年龄,19岁对15岁;P < 0.01),女性比例更高(80%对40%;P < 0.01),黑人比例更高(34%对20%;P < 0.01)。中位随访时间为4.2年(范围,0.03至13年)。在对性别、种族、年龄和尸体供肾(CAD)移植进行校正后,两组间肾移植存活率无差异(P = 0.98)。在狼疮患者中,接受CAD移植的患者失去移植物的可能性是接受活体供肾移植患者的1.9倍(95%置信区间[CI],1.1至3.3;P = 0.02)。在非狼疮受试者中,CAD移植导致移植物失败的风险增加程度较小(风险比,1.3;95% CI,1.2至1.5)。多因素分析显示,狼疮患者死亡的可能性是非狼疮患者的1.8倍(95% CI,1.14至2.74;P = 0.01)。
尽管移植存活率无差异,但与其他儿科肾移植受者相比,狼疮性肾炎儿科患者肾移植后的患者生存率较低。